LEXICON PHARMACEUTICALS, INC.

LXRX · NASDAQ

Pharmaceutical Preparation Manufacturing

Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients' lives. Through its Genome5000™ program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon advanced one of these medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in neuropathic pain, heart failure, diabetes and metabolism and other indications.

Market Data

Price $1.64 -0.02 (-1.20%)

Market Cap$697M

P/E Ratio—

EPS$—

52W High$1.83

52W Low$0.32

Beta1.06

Data from Finnhub · Updated Mar 11, 2026